Your search for comorbidities returned 74 results

Treatment with canagliflozin may not significantly lower risk for myocardial infarction among patients with type 2 diabetes and comorbid chronic kidney disease or among patients with diabetes who have a history of or have a high risk for CVD.

Researchers sought to investigate the relationship between myocarditis and COVID-19 and inform therapeutic treatment.

A new index for multiple chronic conditions was effective for predicting post-stroke functional outcomes and disability/dependency in patients with ischemic stroke.

Second-generation drug-eluting stents (DES) were found to be associated with better clinical outcomes than first-generation DES, 2 years after percutaneous coronary intervention (PCI) in patients with acute myocardial infarction and comorbid prediabetes.

Machine learning methods identified top predictors of coronary artery burden in patients with psoriasis, which were markers related to obesity, dyslipidemia, and inflammation, demonstrating that these are potentially important comorbidities to treat in psoriasis.

A case report of a patient with 20-year, unstable psoriasis who presented with new erthroderma and subsequent treatment with systemic corticosteroids and methotrexate.

Abnormal respiratory vital signs coupled with a set of ECG findings were found to predict early deterioration in patients with COVID-19.

A large majority of older patients hospitalized for heart failure were found to take ≥10 medications.

The American Heart Association and Heart Failure Society released a joint scientific statement summarizing the effects of type 2 diabetes management on heart failure outcomes.

Left atrial appendage thrombosis was found to occur frequently in patients who undergo transfemoral transcatheter aortic valve implantation.